STMN1 and metastatic malignant neoplasm in the lymph nodes: In 2010, Jeon et al. first reported that STMN1 over-expression was positively correlated with lymph node metastasis and advanced staging and vascular invasion, and negatively with recurrence-free survival in diffuse type gastric carcinoma [17].